TAFECTA
TAFECTA
Categories: Anti-Diabetic, BEST SELLER, Diabetic, Endometrial Cancer, Liver Cancer, Lymphoma, ONCOLOGY PRODUCTS, Ovarian Cancer, Pancreatic Cancer, Peritoneal Cancer, Primary Biliary Cirrhosis, Prostate Cancer, Renal Cell Carcinoma
Tags: ACLOPAIN, ACLOPAIN 100 MG, ALECNIB, Anti-viral, BARICINIX 2 MG, Beacon Pharmaceuticals Ltd., Biotech Products, Cancer Medicine in Bangladesh, Oncology Medicine Supplier, Oncology Medicine Supplier in Bangladesh, Oncology Medicines in Bangladesh, TAFECTA
Reviews (0)
Be the first to review “TAFECTA” Cancel reply
Shipping & Delivery
MAECENAS IACULIS
Vestibulum curae torquent diam diam commodo parturient penatibus nunc dui adipiscing
Related products
ALECNIB 150 MG
DESCRIPTION Alecnib, Alectinib Alecnib is an anti-cancer targeted chemotherapy drug used for the treatment of cancer. Alecnib is a tyrosine
HERNIX 40 MG
 Hernix Tablet Neratinib 40 mg Beacon Pharmaceuticals Ltd. Indications Neratinib is a kinase inhibitor indicated for the extended adjuvant treatment of
CRIZOCENT 250 MG
Presentation Crizocent 250: Each capsule contains Crizotinib INN 250 mg Description Crizotinib is an inhibitor of receptor tyrosine kinases including
AXINIX 5 MG
DESCRIPTION Axinix (Axitinib) is a kinase inhibitor indicated for the treatment of advanced renal cell carcinoma after failure of one
AFANIX 40 MG
Afatinib is a kinase inhibitor indicated for the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose
DACLAXEN 60 MG
Indications Daclatasvir is indicated in combination with Sofosbuvir for the treatment of chronic hepatitis C virus (HCV) infection in adults.
Reviews
There are no reviews yet.